Searched for
BIORESORBABLE VASCULAR SCAFFOLD
US gets to the heart of matter, flags concerns on stent pricesThe USTR has raised alarms over India's price caps on coronary stents and high customs duties on drug formulations, arguing it hinders Amer...
Cipla, Alkem Laboratories in final lap to buy SMTPromoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest thei...
Govt mulls over new category for advanced coronary stents, price ceiling increase to attract manufacturersThe government is considering creating a separate category for advanced coronary stents and raising the price ceiling to attract stent make...
Companies seek higher ceiling prices for advanced coronary stentsThe Standing National Committee on Medicines (SNCM), in its recommendation, included coronary stents in the NLEM, 2022 in two categories --...
Drug price regulator exempts Meril Life Sciences from price controls for a stent developed 3 years agoThis means that the firm has provided adequate justification to the government for launching its product at “any price" it wants. Meril Lif...
Prices of 869 formulations to go up by 3.44%: NPPAThe development follows a price revision as per annual Wholesale Price Index (WPI) at the rate of 3.44 percent increase, the National Pharm...
Abbott allowed to discontinue dissolvable stent in IndiaThe company asserted that its decision to withdraw Abbott was based on “low commercial uptake” and this was reflected in the sales figures ...
Government to revisit stent price control in FebruaryThe government is expected to hold discussions to decide on these requests only in February, a year after it first capped prices of these l...
After dissolvable stent 'Absorb', Abbott moves to withdraw 'Xience Alpine'Abbott publicly announced intentions to stop global sales of dissolvable scaffold ‘Absorb’, which has been mired in controversy for risks r...
Abbott to stop sales of bioresorbable stent 'Absorb', moves to withdraw it in IndiaAbbott’s move also comes while several regulators in different countries have scrutinised this scaffold, used in life saving procedures, ov...
Largest-selling stent in India has been banned in EuropeThe development comes in the wake of several studies showing that bioresorbable cardiac stents are not only not superior to existing DES, b...
There is no shortage of coronary stents in the country, claims govtAs per the government, the NPPA was closely monitoring the situation and has alerted the state governments and state drugs controllers to m...
First India-made dissolvable stent gets ministry nodUnlike drug-eluting stents that are made of metal and stay in the arteries forever, Meril’s 100 micron-thick BVS ‘MeRes100’ is made of mate...
NPPA slashes margins on stents for hospitals, distributorsNow, patients purchasing stents at their maximum price won’t pay hospitals margins of more than Rs 2,400 on DES and BVS and about Rs 581 on...
Hospitals not allowed to profit on stents anymore: GovtAccording to data from the drug pricing regulator, hospitals were found earning exorbitant margins on stents—over 650% in some cases.
New stent prices have enough margins: Bhupendra Singh, NPPA"Price capping will make stents more affordable and accessible to patients and new prices leave enough margins to the industry to grow," he...
New stents disappear from hospitals for 're-labelling'Cardiologists told TOI on Thursday the bioresorbable vascular scaffold (BVS)— the fourth generation and most recent one that dissolves into...
Govt slashes cardiac stent prices by over 75 per centIn a notification, the drug regulator has capped the ceiling prices of stentsat Rs 29,600, which currently costs between Rs 40,000 to Rs 1....
NPPA seeks info about pricing, products from stent makersThe National Pharmaceutical Pricing Authority (NPPA) has also called for a meeting with the stakeholders to discuss the issue on January 24.
NPPA to soon fix ceiling prices of stentsThe decision of the Department of Pharmaceuticals comes months after the Ministry of Health in July included stents in the National List of...